text: Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance - Tabular View - ClinicalTrials.gov
  Percentage of subjects on placebo vs peanut SLIT who pass the 54 month double blind, placebo controlled food challenge to assess tolerance. [ Time Frame: 54 months ]
  Complete list of historical versions of study NCT01373242 on ClinicalTrials.gov Archive Site
  Percentage of subjects who demonstrate clinical desensitization by passing the 48 month double-blind, placebo-controlled food challenge. [ Time Frame: 48 months ]
  Induction of clinical tolerance after 48months vs 60 months of peanut SLIT. [ Time Frame: 66 months ]
  The change in immune parameters over time associated with the induction of clinical tolerance versus the failure to achieve clinical tolerance. [ Time Frame: 66 months ]
  Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
  Peanut Sublingual Immunotherapy and Induction of Clinical Tolerance in Peanut Allergic Children (SLIT Tolerance TLC) {Sublingual Immunotherapy for Peanut Allergy}